Financial statements B-Bio
Balance sheet data of B-BIO
|
Year
|
2019
|
2020
|
2022
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 364 396,60 | 3 628 086,30 | 1 177 675,95 | 1 141 398,21 | 257 494,76 |
| A. Fixed assets | 0,00 | 57 093,56 | 1 348,97 | 1 348,97 | 0,00 |
| B. Current assets | 364 396,60 | 3 570 992,74 | 1 176 326,98 | 1 140 049,24 | 257 494,76 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | - | - |
| D. Own shares (stocks) | 0,00 | - | - | - | - |
| Total liabilities | 364 396,60 | 3 628 086,30 | 1 177 675,95 | 1 141 398,21 | 257 494,76 |
| A. Equity | 242 479,72 | -3 730 273,96 | -12 434 702,88 | -12 436 802,88 | -13 330 078,56 |
| B. Liabilities and provisions for liabilities | 121 916,88 | 7 358 360,26 | 13 612 378,83 | 13 578 201,09 | 13 587 573,32 |
| I. Long-term liabilities | 0,00 | 0,00 | - | - | - |
| II. Short-term liabilities | 121 916,88 | 7 258 930,64 | 13 612 378,83 | 13 578 201,09 | 13 587 573,32 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.